Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription

Abstract

The protein product of the retinoblastoma (RB) gene is necessary for the completion of the muscle differentiation program and for myogenic basic helix–loop–helix-dependent transcription. In fact, in addition to induction and maintenance of permanent cell cycle withdrawal through negative regulation of E2F-responsive genes involved in proliferation, pRb also plays a positive role in the activation of muscle-specific genes. In pRb−/− myocytes, the expression of late myogenic markers is defective and myoblast fusion into myotubes occurs without irreversible cell cycle exit. This evidence demonstrates only a partial functional redundancy between pRb and its relatives p107 and pRb2/p130, as these pRb−/− multinucleated cells, which display p107 levels higher than normal myotubes, respond to mitogens with cell cycle re-entry and DNA synthesis. At the molecular level, pRb myogenic functions are mediated by cooperation with MyoD, Myocyte enhancer factor 2 (MEF2), High mobility group box protein-1 (HBP1) and histone deacetylase1, affecting chromatin configuration and tissue-specific transcription, and by post-translational modification in response to intracellular signaling cascades.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Aslanian A, Iaquinta PJ, Verona R, Lees JA . (2004). Genes Dev 18: 1413–1422.

  • Bagella L, MacLachlan TK, Buono RJ, Pisano MM, Giordano A, De Luca A . (1998). J Cell Physiol 177: 206–213.

  • Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB . (2001). Nat Cell Biol 3: 667–674.

  • Classon M, Dyson N . (2001). Exp Cell Res 264: 135–147.

  • De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP et al. (1997). J Biol Chem 272: 20971–20974.

  • Dimova DK, Stevaux O, Frolov MV, Dyson NJ . (2003). Genes Dev 17: 2308–2320.

  • Dyson N . (1998). Genes Dev 12: 2245–2262.

  • Falls HF, Neel JV . (1951). AMA Arch Ophthalmol 46: 367–389.

  • Flemington EK, Speck SH, Kaelin Jr WG . (1993). Proc Natl Acad Sci USA 90: 6914–6918.

  • Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM et al. (1986). Nature 323: 643–646.

  • Frolov MV, Dyson NJ . (2004). J Cell Sci 117 (Part 11): 2173–2181.

  • Giacinti C, Bagella L, Puri PL, Giordano A, Simone C . (2006). J Cell Physiol 206: 807–813.

  • Ginsberg D . (2004). Dev Cell 6: 742–743.

  • Grana X, Luca A, Sang N, Fu Y, Claudio PP, Rosenblatt J et al. (1994). Proc Natl Acad Sci USA 91: 3834–3838.

  • Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B . (1993). Cell 72: 309–324.

  • Guo K, Walsh K . (1997). J Biol Chem 272: 791–797.

  • Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ et al. (1995). Science 267: 1018–1021.

  • Helin K, Ed H . (1993). Trends Cell Biol 3: 43–46.

  • Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E et al. (2004). Dev Cell 6: 673–684.

  • Kitzmann M, Vandromme M, Schaeffer V, Carnac G, Labbe JC, Lamb N et al. (1999). Mol Cell Biol 19: 3167–3176.

  • Knudson AG . (1971). Proc Natl Acad Sci USA 68: 820–823.

  • Lachner M, O'Sullivan RJ, Jenuwein T . (2003). J Cell Sci 116 (Part 11): 2117–2124.

  • Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L et al. (2000). Mol Cell Biol 20: 3626–3632.

  • Magenta A, Cenciarelli C, De Santa F, Fuschi P, Martelli F, Caruso M et al. (2003). Mol Cell Biol 23: 2893–2906.

  • Martelli F, Cenciarelli C, Santarelli G, Polikar B, Felsani A, Caruso M . (1994). Oncogene 9: 3579–3590.

  • Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E et al. (2001). Genes Dev 15: 267–285.

  • Nevins JR . (1992). Science 258: 424–429.

  • Nguyen DX, Baglia LA, Huang SM, Baker CM, McCance DJ . (2004). EMBO J 23: 1609–1618 [E-pub ahead of print 2004 Mar 25. 15].

  • Novitch BG, Mulligan GJ, Jacks T, Lassar AB . (1996). J Cell Biol 135: 441–456.

  • Novitch BG, Spicer DB, Kim PS, Cheung WL, Lassar AB . (1999). Curr Biol 9: 449–459.

  • Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A et al. (1995). Science 267: 1024–1027.

  • Puri PL, Balsano C, Burgio VL, Chirillo P, Natoli G, Ricci L et al. (1997). Oncogene 14: 1171–1184.

  • Puri PL, Iezzi S, Stiegler P, Chen TT, Schiltz RL, Muscat GE et al. (2001). Mol Cell 8: 885–897.

  • Puri PL, Sartorelli V . (2000). J Cell Physiol 85: 155–173.

  • Sellers WR, Kaelin WG . (1996). Biochim Biophys Acta 1288: M1–M5 (Review. Erratum in: Biochim Biophys Acta 1996 Dec 9; 1288(3)).

  • Sellers WR, Novitch BG, Miy'ake S, Heith A, Otterson GA, Kaye FJ et al. (1998). Genes Dev 12: 95–106.

  • Shih HH, Tevosian SG, Yee AS . (1998). Mol Cell Biol 18: 4732–4743.

  • Simone C . (2005). J Cell Physiol 207: 309–314.

  • Simone C, Bagella L, Bellan C, Giordano A . (2002a). Oncogene 21: 4158–4165.

  • Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL . (2004b). Nat Genet 36: 738–743.

  • Simone C, Giordano A . (2001). Front Biosci 6: D1073–D1082 (review).

  • Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G et al. (2002b). Oncogene 21: 4137–4148.

  • Simone C, Stiegler P, Forcales SV, Bagella L, De Luca A, Sartorelli V et al. (2004a). Oncogene 23: 2177–2187.

  • Skapek SX, Rhee J, Kim PS, Novitch BG, Lassar AB . (1996). Mol Cell Biol 16: 7043–7053.

  • Smialowski P, Singh M, Mikolajka A, Majumdar S, Joy JK, Nalabothula N et al. (2005). Biochim Biophys Acta 1750: 48–60 [E-pub ahead of print 2005 Apr 14].

  • Song A, Wang Q, Goebl M, Harrington M . (1998). Mol Cell Biol 18: 4994–4999.

  • Tevosian SG, Shih HH, Mendelson KG, Sheppard KA, Paulson KE, Yee AS . (1997). Genes Dev 11: 383–396.

  • Walsh K, Perlman H . (1997). Curr Opin Genet Dev 7: 597–602 (review).

  • Weintraub H . (1993). Cell 75: 1241–1244 Review.

  • Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX et al. (2000). Cell 101: 79–89.

  • Zhang JM, Wei Q, Zhao X, Paterson BM . (1999a). EMBO J 18: 926–933.

  • Zhang JM, Zhao X, Wei Q, Paterson BM . (1999b). EMBO J 18: 6983–6993.

Download references

Acknowledgements

We thank Marie Basso for her editorial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Simone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Falco, G., Comes, F. & Simone, C. pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription. Oncogene 25, 5244–5249 (2006). https://doi.org/10.1038/sj.onc.1209623

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209623

Keywords

This article is cited by

Search

Quick links